Constarium
← Search

Omics · study · 2026

Cholesterol-Dependent Metabolism Promotes Bedaquiline Tolerance in Mycobacterium tuberculosis by Limiting Energetic Disruption

Listed in NCBI GEO

Bedaquiline (BDQ) is a diarylquinoline antibiotic that targets mycobacterial ATP synthase and is used in the treatment of drug-resistant tuberculosis.

Description

Cholesterol is an important carbon source for Mycobacterium tuberculosis during infection and has been shown to influence antibiotic susceptibility. To investigate how the growth environment shapes the transcriptomic response to BDQ, we performed RNA-seq on M. tuberculosis H37Rv cultures grown in standard medium or cholesterol-supplemented medium (0.2 mM) and treated with low-dose (0.625 μg/mL) or high-dose (2.5 μg/mL) BDQ, or DMSO as vehicle control, for 4 hours.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
RNA sequencing 65%
Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34138514 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title